Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759833 | SCV000889437 | pathogenic | not provided | 2017-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021203 | SCV001182785 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-03-07 | criteria provided, single submitter | clinical testing | The c.380dupA variant, located in coding exon 3 of the MSH2 gene, results from a duplication of A at nucleotide position 380, causing a translational frameshift with a predicted alternate stop codon (p.N127Kfs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |